Discovery of Likely Subtypes of Rare Childhood Brain Tumor Signals Diagnostic Advance
Scientists at St. Jude Children’s Research Hospital and the German Cancer Research Center have identified four subtypes of a rare brain tumor using various molecular techniques. This lays the foundation for more accurate diagnoses and tailored therapies for cancers that are hard to treat. Their research included an extremely in depth analysis for the genetic alterations of primitive neuroectodermal tumors of the central nervous system (CNS-PNET). These tumors are very rare, but aggressive, and are most commonly diagnosed in young children. Researchers found that 61 percent of the CNS-PNET tumors could be reclassified as a different type of brain tumor due to shared molecular features. Based on reclassification, completely different treatments were suggested. Click here to read more.
Microsurgery Course Zurich
March 29-April 1, 2017; Zurich, Switzerland
12th World Congress on Brain Injury
March 29-April 1, 2017; New Orleans
2017 National Neuroscience Review
March 31-April 1, 2017; National Harbor, Md.
Brain & Brain PET 2017
April 1-4, 2017; Berlin, Germany
Neurosurgical Society of America Annual Meeting 2017
April 2-5, 2017; Jacksonville, Fla.